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Experimental Studies on New Therapeutic Approaches in 
Atrial Fibrillation 
  
 
 
1. Increased activity of the enzyme Cathepsin A in diabetes mediates the 
development of an arrhythmogenic, structural substrate and contractile 
remodeling in the atrium.   
 
2. The negative thoracic pressure during obstructive respiratory events in sleep 
apnea triggers shortening in atrial refractoriness and creates an 
arrhythmogenic substrate for atrial fibrillation. 
 
3. Not new highly selective ion channel blockers but „dirty“ multichannel blockers 
are needed to treat atrial fibrillation in obstructive sleep apnea. 
 
4. Modulation of autonomic nervous system by renal denervation: A simple and 
old idea undergoes a revival. 
 
5. Identification of focal ectopic discharges during atrial fibrillation remains a 
challenge. 
 
6. It is important to treat atrial fibrillation early, best before it appears. 
 
7. Not just fibrosis creates a substrate for AF.  
 
8. Device based therapy vs. pharmacological treatment: Hybride strategies will 
win.  
 
9. It is easy to treat AF; at least in rats, pigs and goats.  
 
10. There are at least three things, which are more important than research: 
health, family and friends.  
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